Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms.
about
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptorsEvaluation of the efficacy and safety of ramelteon in subjects with chronic insomniaComparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake DisordersMT1 and MT2 Melatonin Receptors: A Therapeutic PerspectiveMelatonin action in a midbrain vocal-acoustic networkThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsAutomated video analysis system reveals distinct diurnal behaviors in C57BL/6 and C3H/HeN mice.MT1 melatonin receptors mediate somatic, behavioral, and reproductive neuroendocrine responses to photoperiod and melatonin in Siberian hamsters (Phodopus sungorus).Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disordersMelatonin plays a protective role in postburn rodent gut pathophysiology.The effects of melatonin on bovine uniparental embryos development in vitro and the hormone secretion of COCsUnderstanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease.Melatonergic drugs in development.Targeted disruption of the mouse Mel(1b) melatonin receptor.Carbamate Insecticides Target Human Melatonin ReceptorsMelatonin and its receptors: a new class of sleep-promoting agents.Distribution of MT1 melatonin receptor promoter-driven RFP expression in the brains of BAC C3H/HeN transgenic mice.Melatonin attenuates memory impairment induced by Klotho gene deficiency via interactive signaling between MT2 receptor, ERK, and Nrf2-related antioxidant potential.Melatonin membrane receptors in peripheral tissues: distribution and functionsMelatonin administration alters nicotine preference consumption via signaling through high-affinity melatonin receptors.Melatonin Entrains PER2::LUC Bioluminescence Circadian Rhythm in the Mouse Cornea.Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?Melatonin receptor genes in vertebrates.Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.Melatonin signaling and its modulation of PfNF-YB transcription factor expression in Plasmodium falciparum.Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomniaRelationships between Salivary Melatonin Levels, Quality of Sleep, and Stress in Young Japanese FemalesMicrotubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence.Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN miceUnveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.The effects of exogenous melatonin and melatonin receptor blockade on aggression and estrogen-dependent gene expression in male California mice (Peromyscus californicus).Update on melatonin receptors: IUPHAR Review 20.Circadian Pattern of Melatonin MT1 and MT2 Receptor Localization in the Rat Suprachiasmatic Nucleus.An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.Melatonin modulates the light-induced sympathoexcitation and vagal suppression with participation of the suprachiasmatic nucleus in mice.Maternal melatonin selectively inhibits cortisol production in the primate fetal adrenal gland.Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans.Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion.
P2860
Q24623433-41F86FF6-4931-497B-9E32-F9140EB3FCDCQ24675167-951C9521-2915-4BA7-9CBC-56D2D9374890Q24683617-9B3BE9AE-FBA8-455E-B0D1-A76C4CCF0329Q28074572-904BB239-ED62-4F06-B28F-33121D5C06A5Q28083929-2D809E78-A701-4C6E-B1CE-B060CADCC1EDQ30415368-F008CB25-886D-4261-ADD9-0E7AA7C1DB3BQ30486707-99D26DF9-7F57-4ED0-83AA-CD1E60FE96F4Q30537405-7A8E9392-78A7-4CD8-B782-1BEC382AE812Q33634366-2939250B-2A1B-4DC6-A407-5CE6D701DECCQ33854026-4ABB75F7-6BA3-4304-91CD-68055C559B00Q33883802-29AC09E6-C090-4601-95EE-542FF7825893Q33885527-6F8EB77D-95DA-46F0-901B-B2C5E7B6E6C6Q34118849-2A317197-AC16-402F-B9FB-42C79B47B92CQ34440574-F74A71D0-2CA9-47FB-B046-A6D1B6AC5F58Q34463520-9108FF35-5846-4964-93F5-6CB460CC033FQ34548103-364E76DD-3350-4E9B-A87D-D9977F81A29BQ34682298-5C171564-C51C-4761-AA4B-D47AC35103F3Q34992522-ADC914B4-FC64-4DCD-AF84-6BA2370D13CEQ35626942-3E0AD5D4-9296-4861-BB99-2998B3099230Q35784330-09D4651D-5BC7-4B10-8378-30CAC5858FAAQ35788356-1E497C83-4886-444B-9905-61DD4C392504Q35891926-C9694076-047C-44B7-AF36-4E5CDCB0DE46Q36772909-3CE280AD-D45C-49B8-986D-CD20684C7BE3Q36790172-551F3EEC-78A4-4107-8EA9-ABC1C7ABFE01Q37007133-7B1B4B7C-A7AC-4E74-80EF-EB0E9B680B1AQ37007219-413F993F-8289-4098-9E63-B6FD6FA2451AQ37091856-5FAC1CF3-8C87-44CA-8267-1AA7F3C93300Q37109731-A2C31705-339F-439A-885A-3265BB0F44EEQ37233639-053766B3-FA4A-4844-825D-82A4E1AB7EC1Q37253704-FC35F174-FD6F-46DD-AB46-32CAF344B08FQ37292142-789EA550-40B2-4C8D-8C43-896820146BB3Q37404821-A6F8B4FB-0275-43EE-9942-CC301F90F90AQ37714330-EFA62FBF-79EE-40B2-B03B-69B508252C8CQ38868297-05BE8C42-ECF2-4E68-BDE6-DA4EA429A172Q40159317-4C2E4313-70CF-4719-B2BB-DFF2A122050EQ41492642-960D2C8D-BAF9-4DDA-AD43-993C82A9071CQ44300197-1847BF22-FF56-4FCA-8BDB-433E67AD683AQ44691675-462B24A7-FD83-4520-89E8-362D86FFD693Q45086588-AAF8AA72-8F61-4843-8CB9-18EF19B25DF2Q47146884-9A7E8C9E-52E4-4601-B84B-09F0B3D0C485
P2860
Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Selective MT2 melatonin recept ...... advances of circadian rhythms.
@ast
Selective MT2 melatonin recept ...... advances of circadian rhythms.
@en
Selective MT2 melatonin recept ...... advances of circadian rhythms.
@nl
type
label
Selective MT2 melatonin recept ...... advances of circadian rhythms.
@ast
Selective MT2 melatonin recept ...... advances of circadian rhythms.
@en
Selective MT2 melatonin recept ...... advances of circadian rhythms.
@nl
prefLabel
Selective MT2 melatonin recept ...... advances of circadian rhythms.
@ast
Selective MT2 melatonin recept ...... advances of circadian rhythms.
@en
Selective MT2 melatonin recept ...... advances of circadian rhythms.
@nl
P2093
P1433
P1476
Selective MT2 melatonin recept ...... advances of circadian rhythms.
@en
P2093
P304
P407
P577
1998-09-01T00:00:00Z